| 31st Oct 2025 3:59 pm |
RNS |
Total Voting Rights |
| 31st Oct 2025 7:00 am |
RNS |
Corporate Structure Update and Issue of Options |
| 27th Oct 2025 7:00 am |
RNS |
Appoints global biopharma leader Paul Carter |
| 16th Oct 2025 7:00 am |
RNS |
Raises £1.25 Million to Accelerate Programmes |
| 30th Sep 2025 7:00 am |
RNS |
Half-year Report |
| 28th Aug 2025 7:00 am |
RNS |
Solvonis secures exclusive CNS collaboration |
| 13th Aug 2025 3:03 pm |
RNS-R |
Media Coverage: Small Cap Idea profile |
| 12th Aug 2025 7:00 am |
RNS |
SVN-SDN-14 PTSD - Positive pre-clinical results |
| 31st Jul 2025 4:30 pm |
RNS |
Total Voting Rights |
| 22nd Jul 2025 7:00 am |
RNS |
Translational Bridging Studies |
| 18th Jul 2025 11:03 am |
RNS |
Exercise of warrants |
| 14th Jul 2025 7:00 am |
RNS-R |
Solvonis Chair to speak at Lucid Capital Markets |
| 11th Jul 2025 7:00 am |
RNS |
£1m subscription to accelerate AI drug discovery |
| 8th Jul 2025 7:00 am |
RNS |
Holding(s) in Company |
| 27th Jun 2025 2:38 pm |
RNS |
AGM Statement |
| 27th Jun 2025 8:54 am |
RNS |
Holding(s) in Company |
| 26th Jun 2025 10:21 am |
RNS-R |
Initiation of Research Coverage |
| 23rd Jun 2025 7:00 am |
RNS |
Allowance of U.S. patent covering AI-supported CNS |
| 11th Jun 2025 7:30 am |
RNS |
Initiation of AI supported CNS drug discovery |
| 5th Jun 2025 7:00 am |
RNS |
Synthesis of development candidate for SVN-SDN-014 |
| 3rd Jun 2025 4:30 pm |
RNS |
Notice of Annual General Meeting |
| 3rd Jun 2025 7:00 am |
RNS |
Appointment of Prof. David Nutt as CSO |
| 2nd Jun 2025 11:58 am |
RNS |
Holding(s) in Company |
| 30th May 2025 5:00 pm |
RNS |
Total Voting Rights |
| 29th May 2025 3:11 pm |
RNS |
Holding(s) in Company |
| 29th May 2025 12:02 pm |
RNS |
Holding(s) in Company |
| 29th May 2025 10:30 am |
RNS |
Holding(s) in Company |
| 29th May 2025 7:00 am |
RNS-R |
Presentation at Mello2025 |
| 28th May 2025 7:30 am |
RNS |
Holding(s) in Company |
| 28th May 2025 7:00 am |
RNS |
Completion of the acquisition of Awakn |
| 21st May 2025 3:24 pm |
RNS |
Publication of a Prospectus |
| 16th May 2025 7:31 am |
RNS |
Result of placing |
| 15th May 2025 4:53 pm |
RNS |
Proposed equity fundraising via ABB |
| 28th Apr 2025 11:30 am |
RNS |
Result of General Meeting |
| 23rd Apr 2025 7:00 am |
RNS |
Proposed acquisition of Awakn approved |
| 16th Apr 2025 7:00 am |
RNS |
Final Results for the year ended 31 December 2024 |
| 10th Apr 2025 2:00 pm |
RNS |
Posting of Circular and Notice of General Meeting |
| 7th Apr 2025 7:00 am |
RNS |
Holding(s) in Company |
| 4th Apr 2025 7:00 am |
RNS |
Engagement of PharmaVentures |
| 26th Mar 2025 7:00 am |
RNS |
Positive progress on European Patent Application |
